A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma

NCT04552977 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: fluzoparil
DRUG: temozolomide

Sponsor

Shandong Cancer Hospital and Institute